questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins atténués
Vaccins atténués : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vaccins atténués
Agents pathogènes
Immunisation
Tests sérologiques
Efficacité des vaccins
Immunité
Symptômes
2
Réactions aux vaccins
Effets secondaires
Fièvre
Maladies infectieuses
Réactions indésirables
Vaccins
Prévention
2
Préparation à la vaccination
Antécédents médicaux
Vaccins
Immunodépression
Sécurité des vaccins
Vaccins atténués
Traitements
2
Réactions allergiques
Traitement médical
Vaccins
Antécédents médicaux
Prévention
Vaccins
Complications
2
Complications
Infections
Vaccins atténués
Surveillance médicale
Effets indésirables
Vaccins
Facteurs de risque
2
Immunodépression
Grossesse
Vaccins atténués
Allergies
Évaluation médicale
Vaccins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins atténués : Questions médicales les plus fréquentes",
"headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins atténués"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins atténués",
"alternateName": "Vaccines, Attenuated",
"code": {
"@type": "MedicalCode",
"code": "D014613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Aitor Nogales",
"url": "https://questionsmedicales.fr/author/Aitor%20Nogales",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com."
}
},
{
"@type": "Person",
"name": "Charles Grose",
"url": "https://questionsmedicales.fr/author/Charles%20Grose",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA."
}
},
{
"@type": "Person",
"name": "Manish Patel",
"url": "https://questionsmedicales.fr/author/Manish%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov."
}
},
{
"@type": "Person",
"name": "Jessie R Chung",
"url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mitochondrial Factors in the Cell Nucleus.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37686461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241713656"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Material Properties of the Cell Nucleus: A Matter of Scale.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37566037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12151958"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36460793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s12276-022-00892-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Measurement of the Compressibility of Cell and Nucleus Based on Acoustofluidic Microdevice.",
"datePublished": "2022-07-14",
"url": "https://questionsmedicales.fr/article/35913194",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64225"
}
},
{
"@type": "ScholarlyArticle",
"name": "ANNEXIN A1: Roles in Placenta, Cell Survival, and Nucleus.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35805141",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11132057"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins atténués",
"item": "https://questionsmedicales.fr/mesh/D014613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins atténués - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins atténués",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins atténués",
"description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins atténués",
"description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins atténués",
"description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins atténués",
"description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins atténués",
"description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins atténués",
"description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Cell+Nucleus#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un vaccin est atténué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents."
}
},
{
"@type": "Question",
"name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après un vaccin atténué ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués causent-ils des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée."
}
},
{
"@type": "Question",
"name": "Comment se préparer avant de recevoir un vaccin atténué ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués sont-ils sûrs pour tous ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction sévère à un vaccin atténué ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter immédiatement un professionnel de santé pour évaluer la situation."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués nécessitent-ils un traitement préventif ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un vaccin atténué ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les complications des vaccins atténués sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les vaccins atténués ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Vaccins atténués" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.
Publications dans "Vaccins atténués" :
The origin of eukaryotic organisms involved the integration of mitochondria into the ancestor cell, with a massive gene transfer from the original proteobacterium to the host nucleus. Thus, mitochondr...
Chromatin regulatory processes physically take place in the environment of the cell nucleus, which is filled with the chromosomes and a plethora of smaller biomolecules. The nucleus contains macromole...
Single-cell ribonucleic acid (RNA) sequencing (scRNA-seq) is an effective technique for estimating the cellular composition and transcriptional profiles of individual cells from fresh tissue. Single-n...
Cell mechanics play an important role in tumor metastasis, malignant transformation of cells, and radiosensitivity. During these processes, studying the mechanical properties of the cells is often cha...
The unbiased approaches of the last decade have enabled the collection of new data on the biology of annexin A1 (ANXA1) in a variety of scientific aspects, creating opportunities for new biomarkers an...
DNA architectural proteins play a major role in organization of chromosomal DNA in living cells by packaging it into chromatin, whose spatial conformation is determined by an intricate interplay betwe...
The HIV-1 genome encodes a small number of proteins with structural, enzymatic, regulatory, and accessory functions. These viral proteins interact with a number of host factors to promote the early an...
Hepatitis B virus (HBV) capsid assembly is traditionally thought to occur predominantly in the cytoplasm, where the virus gains access to the virion egress pathway. To better define sites of HBV capsi...
Cells actively position their nuclei based on their activity. In fission yeast, microtubule-dependent nuclear centering is critical for symmetrical cell division. After spindle disassembly at the end ...
Acute monocytic leukemia-M5 (AML-M5) remains a challenging disease due to its high morbidity and poor prognosis. In addition to the evidence mentioned earlier, several studies have shown that programm...
THP-1 cells were mainly treated with Erastin and IMP-366. The changes of ferroptosis and necroptosis levels were detected by CCK-8, western blot, quantitative real-time PCR, and electron microscopy. F...
The addition of the myristoylation inhibitor IMP-366 to erastin-treated acute monocytic leukemia cell line THP-1 cell not only resulted in greater susceptibility to ferroptosis characterized by lipid ...
We demonstrated that inhibition of myristoylation by IMP-366 is capable of switching ferroptosis and ferroptosis-dependent necroptosis in THP-1 cells. In these findings, FSP1-mediated ferroptosis and ...